{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:45:54Z","timestamp":1788219954139,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T00:00:00Z","timestamp":1347321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The clinical outcomes of ST-segment elevation myocardial infarction (STEMI) are poor in patients with renal insufficiency. This study investigated changes in the likelihood that patients received optimal medical care throughout the entire process of myocardial infarction management, on the basis of their glomerular filtration rate (GFR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study analyzed 7,679 patients (age, 63\u2009\u00b1\u200913\u2009years; men 73.6%) who had STEMI and were enrolled in the Korea Acute Myocardial Infarction Registry (KAMIR) from November 2005 to August 2008. The study subjects were divided into 5 groups corresponding to strata used to define chronic kidney disease stages.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Patients with lower GFR were less likely to present with typical chest pain. The average symptom-to-door time, door-to-balloon time, and symptom-to-balloon time were longer with lower GFR than higher GFR. Primary reperfusion therapy was performed less frequently and the results of reperfusion therapy were poorer in patients with renal insufficiency; these patients were less likely to receive adjunctive medical treatment, such as treatment with aspirin, clopidogrel, \u03b2-blocker, angiotensin-converting enzyme (ACE) inhibitor\/angiotensin-receptor blocker (ARB), or statin, during hospitalization and at discharge. Patients who received less intense medical therapy had worse clinical outcomes than those who received more intense medical therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Patients with STEMI and renal insufficiency had less chance of receiving optimal medical care throughout the entire process of MI management, which may contribute to worse outcomes in these patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2369-13-110","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T22:38:41Z","timestamp":1347403121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Suboptimal medical care of patients with ST-Elevation Myocardial Infarction and Renal Insufficiency: results from the Korea acute Myocardial Infarction Registry"],"prefix":"10.1186","volume":"13","author":[{"given":"Joon Seok","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Seong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hui","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Kwon","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong Chan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,11]]},"reference":[{"key":"327_CR1","doi-asserted-by":"crossref","unstructured":"VI. Causes of death in ESRD. Am J Kidney Dis. 1999, 34 (2 Suppl 1): S87-S94.","DOI":"10.1016\/S0272-6386(99)80018-3"},{"issue":"2 Suppl 1","key":"327_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0272-6386(99)80009-2","volume":"34","author":"RA Wolfe","year":"1999","unstructured":"Wolfe RA, Port FK, Webb RL, Bloembergen WE, Hirth R, Young EW, Ojo AO, Strawderman RL, Parekh R, Stack A, et al: Introduction to the excerpts from the United States Renal Data System 1999 Annual Data Report. Am J Kidney Dis. 1999, 34 (2 Suppl 1): S1-S3.","journal-title":"Am J Kidney Dis"},{"issue":"13","key":"327_CR3","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMoa041365","volume":"351","author":"NS Anavekar","year":"2004","unstructured":"Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, et al: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004, 351 (13): 1285-1295. 10.1056\/NEJMoa041365.","journal-title":"N Engl J Med"},{"issue":"6","key":"327_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1053\/j.ajkd.2012.01.016","volume":"59","author":"LS Bae EH","year":"2012","unstructured":"Bae EH LS, Cho KH, Choi JS, Kim CS, Park JW, Ma SK, Jeong MH, Kim SW: Glomerular filtration rate and cardiovascular outcomes after acute myocardial infarction: Results from Korea Acute Myocardial infarction Registry. American J Kidney Dis. 2012, 59 (6): 795-802. 10.1053\/j.ajkd.2012.01.016.","journal-title":"American J Kidney Dis"},{"issue":"17","key":"327_CR5","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1001\/archinte.166.17.1884","volume":"166","author":"NI Parikh","year":"2006","unstructured":"Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS: Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med. 2006, 166 (17): 1884-1891. 10.1001\/archinte.166.17.1884.","journal-title":"Arch Intern Med"},{"issue":"2","key":"327_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R: Atherosclerosis\u2013an inflammatory disease. N Engl J Med. 1999, 340 (2): 115-126. 10.1056\/NEJM199901143400207.","journal-title":"N Engl J Med"},{"issue":"3","key":"327_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ahj.2011.06.006","volume":"162","author":"H Skali","year":"2011","unstructured":"Skali H, Uno H, Levey AS, Inker LA, Pfeffer MA, Solomon SD: Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation. Am Heart J. 2011, 162 (3): 548-554. 10.1016\/j.ahj.2011.06.006.","journal-title":"Am Heart J"},{"key":"327_CR8","unstructured":"Choi JS KC, Park JW, Bae EH, Ma SK, Jeong MH, Kim SW: Renal Dysfunction as a Risk Factor for Painless Myocardial Infarction: Results from Korea Acute Myocardial Infarction Registry. Clin Res Cardiol. Epub ahead of print"},{"issue":"24","key":"327_CR9","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1001\/jama.283.24.3223","volume":"283","author":"JG Canto","year":"2000","unstructured":"Canto JG, Shlipak MG, Rogers WJ, Malmgren JA, Frederick PD, Lambrew CT, Ornato JP, Barron HV, Kiefe CI: Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000, 283 (24): 3223-3229. 10.1001\/jama.283.24.3223.","journal-title":"JAMA"},{"issue":"16","key":"327_CR10","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/01.CIR.97.16.1549","volume":"97","author":"AM Ross","year":"1998","unstructured":"Ross AM, Coyne KS, Moreyra E, Reiner JS, Greenhouse SW, Walker PL, Simoons ML, Draoui YC, Califf RM, Topol EJ, et al: Extended mortality benefit of early postinfarction reperfusion, GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial. Circulation. 1998, 97 (16): 1549-1556. 10.1161\/01.CIR.97.16.1549.","journal-title":"Circulation"},{"issue":"7","key":"327_CR11","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1161\/01.CIR.91.7.1923","volume":"91","author":"RJ Simes","year":"1995","unstructured":"Simes RJ, Topol EJ, Holmes DR, White HD, Rutsch WR, Vahanian A, Simoons ML, Morris D, Betriu A, Califf RM: Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation. 1995, 91 (7): 1923-1928. 10.1161\/01.CIR.91.7.1923.","journal-title":"Circulation"},{"issue":"8","key":"327_CR12","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1161\/01.CIR.0000027560.41358.B3","volume":"106","author":"J Al Suwaidi","year":"2002","unstructured":"Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, Granger CB, Ohman EM, Holmes DR: Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002, 106 (8): 974-980. 10.1161\/01.CIR.0000027560.41358.B3.","journal-title":"Circulation"},{"issue":"9","key":"327_CR13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/heart.89.9.1003","volume":"89","author":"JJ Santopinto","year":"2003","unstructured":"Santopinto JJ, Fox KA, Goldberg RJ, Budaj A, Pinero G, Avezum A, Gulba D, Esteban J, Gore JM, Johnson J, et al: Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart. 2003, 89 (9): 1003-1008. 10.1136\/heart.89.9.1003.","journal-title":"Heart"},{"issue":"3","key":"327_CR14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.V83475","volume":"8","author":"BN Becker","year":"1997","unstructured":"Becker BN, Himmelfarb J, Henrich WL, Hakim RM: Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol. 1997, 8 (3): 475-486.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"327_CR15","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1093\/ndt\/gfg181","volume":"18","author":"E Cauza","year":"2003","unstructured":"Cauza E, Kletzmaier J, Bodlaj G, Dunky A, Herrmann W, Kostner K: Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function. Nephrol Dial Transplant. 2003, 18 (8): 1568-1572. 10.1093\/ndt\/gfg181.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"327_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1291\/hypres.26.479","volume":"26","author":"Y Dohi","year":"2003","unstructured":"Dohi Y, Ohashi M, Sugiyama M, Takase H, Sato K, Ueda R: Circulating thrombomodulin levels are related to latent progression of atherosclerosis in hypertensive patients. Hypertens Res. 2003, 26 (6): 479-483. 10.1291\/hypres.26.479.","journal-title":"Hypertens Res"},{"issue":"1\u20132","key":"327_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-8981(03)00338-3","volume":"336","author":"C Fleck","year":"2003","unstructured":"Fleck C, Schweitzer F, Karge E, Busch M, Stein G: Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. Clin Chim Acta. 2003, 336 (1\u20132): 1-12.","journal-title":"Clin Chim Acta"},{"issue":"7","key":"327_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","volume":"137","author":"RS Wright","year":"2002","unstructured":"Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS: Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002, 137 (7): 563-570.","journal-title":"Ann Intern Med"},{"issue":"3","key":"327_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","volume":"121","author":"CS Fox","year":"2010","unstructured":"Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, Saucedo JF, Kontos MC, Wiviott SD: Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation. 2010, 121 (3): 357-365. 10.1161\/CIRCULATIONAHA.109.865352.","journal-title":"Circulation"},{"issue":"17","key":"327_CR20","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1001\/archinte.160.17.2645","volume":"160","author":"CD Frances","year":"2000","unstructured":"Frances CD, Noguchi H, Massie BM, Browner WS, McClellan M: Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function. Arch Intern Med. 2000, 160 (17): 2645-2650. 10.1001\/archinte.160.17.2645.","journal-title":"Arch Intern Med"},{"issue":"6","key":"327_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0002-9343(01)00652-0","volume":"110","author":"MG Shlipak","year":"2001","unstructured":"Shlipak MG, Browner WS, Noguchi H, Massie B, Frances CD, McClellan M: Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. Am J Med. 2001, 110 (6): 425-433. 10.1016\/S0002-9343(01)00652-0.","journal-title":"Am J Med"},{"issue":"2","key":"327_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0735-1097(03)00572-2","volume":"42","author":"AK Berger","year":"2003","unstructured":"Berger AK, Duval S, Krumholz HM: Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol. 2003, 42 (2): 201-208. 10.1016\/S0735-1097(03)00572-2.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"327_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1161\/01.CIR.85.1.172","volume":"85","author":"PG McGovern","year":"1992","unstructured":"McGovern PG, Folsom AR, Sprafka JM, Burke GL, Doliszny KM, Demirovic J, Naylor JD, Blackburn H: Trends in survival of hospitalized myocardial infarction patients between 1970 and 1985. The Minnesota Heart Survey. Circulation. 1992, 85 (1): 172-179. 10.1161\/01.CIR.85.1.172.","journal-title":"Circulation"},{"issue":"2","key":"327_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10900-011-9466-3","volume":"37","author":"H Kilburn","year":"2011","unstructured":"Kilburn H, Schoen L, Wang T: Acute Myocardial Infarction in New York State: 1996\u20132008. J Community Health. 2011, 37 (2): 473-479.","journal-title":"J Community Health"},{"issue":"9","key":"327_CR25","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1253\/circj.CJ-08-0088","volume":"72","author":"SH Lee","year":"2008","unstructured":"Lee SH, Kim YJ, Kim W, Park JS, Shin DG, Hur SH, Kim CJ, Cho MC, Chae SC, Jeong MH, et al: Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the Korean Acute Myocardial Infarction Registry. Circ J. 2008, 72 (9): 1410-1418. 10.1253\/circj.CJ-08-0088.","journal-title":"Circ J"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-13-110\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:00:39Z","timestamp":1630526439000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-13-110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-13-110","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,11]]},"assertion":[{"value":"4 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"110"}}